Skip to the open sheet
Before the planA peptide care workbook

Read. Ask. Leave room for an answer.

Questions before a care plan

Keep the unanswered claims in plain sight.

A badge, a familiar name, or a fast checkout cannot answer every question. Ask for the underlying record.

The medicine and advertising position here was checked September 26, 2026.

Claims that need more than a reassuring reply

Supplying a prescription medicine to someone who has no prescription breaks federal law.

The rule is in section 353(b)(1), which covers supplying medicines on a prescription.

For a pharmacy-made (compounded) medicine, claiming FDA (the Food and Drug Administration) approval misstates what the product is.

The FDA also identifies claims that a compounded preparation is a generic of an approved product as false or misleading.

“Research-only” means the label presents the product as something for research, rather than medicine for people. In warning letters, the FDA said some sellers were still marketing these products for human use. Sending those unapproved medicines to customers in other states broke federal law, the agency said, despite the labels.

The Federal Trade Commission warns that a sales page can display fabricated seals or guarantees.

The Federal Trade Commission, or FTC, is a US consumer protection agency. For each disputed claim, ask which record supports it. A repeated slogan is still a missing answer.

Questions to leave open until answered
Write the claim next to the proof

Notes for this chapter